We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+7.67%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$26.7B
AUM Growth
+$3.85B
Cap. Flow
-$4.59B
Cap. Flow %
-17.17%
Top 10 Hldgs %
20.41%
Holding
1,231
New
232
Increased
271
Reduced
149
Closed
114
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JETS icon
151
CALL
US Global Jets ETF
JETS
$768M
$24.5M 0.09%
1,160,000
+375,000
+48% +$8.36M
GILD icon
152
Gilead Sciences
GILD
$162B
$24.3M 0.09%
334,952
+11,018
+3% +$759K
MO icon
153
Altria Group
MO
$122B
$24.2M 0.09%
510,131
+17,474
+4% +$801K
CZR icon
154
Caesars Entertainment
CZR
$6.1B
$24.1M 0.09%
257,689
+15,265
+6% +$1.55M
RCL icon
155
Royal Caribbean
RCL
$81.8B
$24M 0.09%
311,820
+45,737
+17% +$3.72M
DXCM icon
156
DexCom
DXCM
$28.3B
$23.6M 0.09%
175,768
-4,096
-2% -$589K
EMR icon
157
Emerson Electric
EMR
$83.6B
$22.8M 0.09%
245,544
+9,506
+4% +$895K
DUK icon
158
Duke Energy
DUK
$100B
$22.8M 0.09%
217,564
+8,422
+4% +$854K
KMI icon
159
Kinder Morgan
KMI
$70.6B
$22.5M 0.08%
1,421,593
+590,104
+71% +$9.82M
DHI icon
160
D.R. Horton
DHI
$41.3B
$22.2M 0.08%
204,649
-65,184
-24% -$6.28M
APD icon
161
Air Products & Chemicals
APD
$65.2B
$22M 0.08%
72,404
+2,803
+4% +$823K
DE icon
162
Deere & Co
DE
$169B
$21.6M 0.08%
62,954
+2,356
+4% +$820K
MMM icon
163
3M
MMM
$91.9B
$21.6M 0.08%
145,269
+5,624
+4% +$838K
SOLN
164
DELISTED
The Southern Company
SOLN
$21.5M 0.08%
400,000
HES
165
DELISTED
Hess
HES
$21.2M 0.08%
286,272
-48,082
-14% -$3.9M
AEPPZ
166
DELISTED
American Electric Power Company, Inc. Corporate Units
AEPPZ
$21M 0.08%
400,000
CE icon
167
Celanese
CE
$4.87B
$20.9M 0.08%
124,583
+28,968
+30% +$4.72M
UBS icon
168
UBS Group
UBS
$172B
$20.7M 0.08%
1,156,652
-18,075
-2% -$318K
TSM icon
169
TSMC
TSM
$2.07T
$20.7M 0.08%
171,648
+11,089
+7% +$1.3M
MGM icon
170
MGM Resorts International
MGM
$11.8B
$20.6M 0.08%
458,136
+8,248
+2% +$370K
EWY icon
171
CALL
iShares MSCI South Korea ETF
EWY
$22.5B
$20.3M 0.08%
+261,300
New +$20.7M
FRC
172
DELISTED
First Republic Bank
FRC
$20.3M 0.08%
98,335
+3,807
+4% +$803K
RRAC.U
173
DELISTED
Rigel Resource Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-half of one redeemable warrant
RRAC.U
$20.3M 0.08%
+2,000,000
New +$20.2M
LGSTU
174
DELISTED
Semper Paratus Acquisition Corporation Unit
LGSTU
$20.3M 0.08%
+2,000,000
New +$20.2M
SUAC.U
175
DELISTED
ShoulderUp Technology Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
SUAC.U
$20.2M 0.08%
+2,000,000
New +$20.1M

Similar funds

Calamos Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Calamos Advisors held 1,231 positions worth $26.7B, up 17% from $22.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Calamos Advisors withdrew a net $4.59B in Q4 2021, closing 114 positions and reducing 149 holdings. Its most notable exit was AstraZeneca, an estimated $17.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A worth $169M.

  • Calamos Advisors's largest Q4 2021 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 81,590 shares worth $169M.
  • Calamos Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $151M increase.
  • Calamos Advisors's biggest Q4 2021 reduction was JPMorgan Chase, cutting an estimated $29.5M.
  • Calamos Advisors fully exited AstraZeneca in Q4 2021, selling an estimated $17.8M.
  • Calamos Advisors's ten largest holdings make up 20% of its $26.7B portfolio in Q4 2021.
  • Calamos Advisors opened 232 new positions and closed 114 in Q4 2021.
  • Calamos Advisors's portfolio value rose 17% quarter-over-quarter to $26.7B.

Based on Calamos Advisors's 13F filing for Q4 2021, filed 1 Feb 2022.